Therapeutic Antibody discovery platform
MilleGen is expert in the development of human therapeutic antibodies with higher effectiveness. We have developed a pipeline of human antibody leads against original targets involved in cancers which include also our breakthrough technology of Fc domain genetic engineering to propose therapeutic antibodies with superior activities (more potent, safer and longer lasting) to improve patient outcomes.
We propose our know-how in therapeutic antibody development to perform: (1) isolation of human antibodies, (2) anti-idiotypic antibodies (3) affinity maturation, (4) optimization of therapeutic antibody efficiency and (4) develop collaboration to realize the clinical studies of our validated antibody candidates.
VALIDATED ANTIBODY PLATFORM:
- Fully human antibody selection
- Anti-idiotypic antibodies isolating from our antibody library
- Successful projects delivered on time
- Highly skilled and experienced scientific team
- Screening designed to your target specificity
- Independent company: proprietary human antibody library
- Original diversity of the library
- 12 years of experience in biotechnology
